Estimating fetal exposure to the P‐gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome
Abstract We have previously developed a maternal‐fetal physiologically‐based pharmacokinetic (m‐f PBPK) model to dynamically predict (and verify) fetal‐maternal exposure to drugs that passively diffuse across the placenta. Here, we extended the application of this model to dynamically predict fetal...
Main Authors: | Olena Anoshchenko, Mark A. Milad, Jashvant D. Unadkat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12674 |
Similar Items
-
Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
by: Fatma Mohamed, et al.
Published: (2021-04-01) -
The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
by: Suada Heljić, et al.
Published: (2009-08-01) -
Corticosteroids in acute respiratory distress syndrome
by: A.B.S. Fernandes, et al.
Published: (2005-02-01) -
Antenatal corticosteroids and incidence of neonatal respiratory distress after elective caesarean section in late preterm and term neonates
by: Aida de la Huerga López, et al.
Published: (2019-12-01) -
Antenatal treatment with corticosteroids for preterm neonates: impact on the incidence of respiratory distress syndrome and intra-hospital mortality
by: Joice Fabíola Meneguel, et al.